UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Blood, ISSN 0006-4971, 06/2012, Volume 119, Issue 25, pp. 5996 - 6004
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Immunopathology | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Biological and medical sciences | Immunoglobulinopathies | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Infection - therapy | Vasculitis - epidemiology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Data Collection | Cryoglobulinemia - complications | Vasculitis - complications | Cryoglobulinemia - epidemiology | Infection - epidemiology | Female | Retrospective Studies | Vasculitis - therapy | Cryoglobulinemia - therapy | Rituximab | Treatment Outcome | Combined Modality Therapy | Adrenal Cortex Hormones - adverse effects | Algorithms | Antibodies, Monoclonal - administration & dosage | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Infection - complications | Adrenal Cortex Hormones - administration & dosage | Cohort Studies | Index Medicus | Abridged Index Medicus | Cryoglobulinemia | Antibodies, Monoclonal, Murine-Derived | Adrenal Cortex Hormones | Antibodies, Monoclonal | Infection | Life Sciences | Vasculitis
Journal Article
The Journal of biological chemistry, ISSN 0021-9258, 02/2014, Volume 289, Issue 7, pp. 4273 - 4285
Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Humans | Ectodysplasins - metabolism | Ectodysplasins - immunology | Molecular Sequence Data | Male | Antibodies, Monoclonal, Murine-Derived - toxicity | Antibodies, Neutralizing - immunology | Ectodermal Dysplasia - metabolism | Cattle | Mice, Mutant Strains | Base Sequence | Ectodermal Dysplasia - pathology | Female | Cell Line | Antibodies, Monoclonal, Murine-Derived - immunology | Ectodysplasins - genetics | Ectodermal Dysplasia - immunology | Antibodies, Neutralizing - genetics | Ectodermal Dysplasia - chemically induced | Pregnancy | Autoantibodies - immunology | Animals | Autoantibodies - toxicity | Dogs | Ectodysplasins - antagonists & inhibitors | Ectodermal Dysplasia - genetics | Mice | Antibodies, Monoclonal, Murine-Derived - genetics | Autoantibodies - genetics | Antibodies, Neutralizing - toxicity | Index Medicus | Antibodies | Embryo | Receptors | Tooth | Developmental Biology | Tumor Necrosis Factor (TNF)
Journal Article
Blood, ISSN 0006-4971, 10/2013, Volume 122, Issue 18, pp. 3160 - 3164
Life Sciences & Biomedicine | Hematology | Science & Technology | Breast Neoplasms - immunology | Humans | Melanoma, Experimental - drug therapy | Antibody-Dependent Cell Cytotoxicity - immunology | Receptors, IgG - metabolism | Receptors, IgG - genetics | Melanoma, Experimental - immunology | Antibodies, Monoclonal, Humanized - pharmacology | Neutrophils - metabolism | Antibodies, Monoclonal - immunology | Antibody-Dependent Cell Cytotoxicity - genetics | Antibodies, Monoclonal, Murine-Derived - immunology | Antibodies, Monoclonal - pharmacology | Mice, Inbred C57BL | Neutrophils - drug effects | Neutrophils - immunology | Rituximab | Mice, Transgenic | Receptors, IgG - immunology | Breast Neoplasms - drug therapy | Mice, Knockout | Xenograft Model Antitumor Assays | Animals | Breast Neoplasms - genetics | Melanoma, Experimental - genetics | Tumor Burden - drug effects | Mice, Nude | Cell Line, Tumor | Mice | Antibodies, Monoclonal, Humanized - immunology | Antibodies, Monoclonal, Murine-Derived - pharmacology | Antibody-Dependent Cell Cytotoxicity - drug effects | Trastuzumab | Tumor Burden - immunology | Index Medicus | Abridged Index Medicus | Antibodies, Monoclonal, Murine-Derived | Antibody-Dependent Cell Cytotoxicity | Neutrophils | Antibodies, Monoclonal | Tumor Burden | Breast Neoplasms | Life Sciences | Receptors, IgG | Antibodies, Monoclonal, Humanized | Immunology | Melanoma, Experimental | Immunotherapy | 12 | 34 | Immunobiology | Brief Report | 6
Journal Article
Blood, ISSN 0006-4971, 02/2011, Volume 117, Issue 8, pp. 2423 - 2432
Life Sciences & Biomedicine | Hematology | Science & Technology | Antigens, CD20 - immunology | Antibody-Dependent Cell Cytotoxicity | Antibodies, Monoclonal - pharmacology | Humans | Tumor Necrosis Factor Receptor Superfamily, Member 9 - immunology | Rituximab | Antibodies, Monoclonal - therapeutic use | Tumor Necrosis Factor Receptor Superfamily, Member 9 - genetics | Drug Synergism | Xenograft Model Antitumor Assays | Animals | Tumor Cells, Cultured | Antibodies, Monoclonal, Murine-Derived - pharmacology | Index Medicus | Abridged Index Medicus | Life Sciences | Antibodies, Monoclonal, Murine-Derived | Antigens, CD20 | Antibodies, Monoclonal | Antigens, CD137 | Cancer | Lymphoid Neoplasia
Journal Article
The lancet oncology, ISSN 1470-2045, 2012, Volume 13, Issue 2, pp. 196 - 206
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Doxorubicin - therapeutic use | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prednisolone - administration & dosage | Prospective Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Organ Transplantation - pathology | Cyclophosphamide - therapeutic use | Epstein-Barr Virus Infections - therapy | Vincristine - administration & dosage | Adult | Female | Herpesvirus 4, Human - pathogenicity | Prednisolone - therapeutic use | France | Lymphoproliferative Disorders - etiology | Doxorubicin - administration & dosage | Antigens, CD20 - immunology | Rituximab | Lymphoproliferative Disorders - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Organ Transplantation - adverse effects | Adolescent | Vincristine - therapeutic use | Epstein-Barr Virus Infections - diagnosis | Lymphoproliferative Disorders - drug therapy | Aged | Germany | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Anthracyclines | Cyclophosphamide | Chemotherapy | Corticosteroids | Organ transplant recipients | Clinical trials | Product development | Epstein-Barr virus | Universities and colleges | Prednisolone | Cancer | Index Medicus | Antibodies, Monoclonal, Murine-Derived | Antigens, CD20 | Lymphoproliferative Disorders | Antineoplastic Combined Chemotherapy Protocols | Organ Transplantation | Vincristine | Doxorubicin | Herpesvirus 4, Human | Life Sciences | Immunology | Epstein-Barr Virus Infections
Journal Article
The Journal of immunology (1950), ISSN 0022-1767, 08/2011, Volume 187, Issue 4, pp. 1754 - 1763
Life Sciences & Biomedicine | Immunology | Science & Technology | Antibodies, Monoclonal, Murine-Derived - immunology | Antineoplastic Agents - immunology | Immunologic Capping - immunology | Antibodies, Monoclonal, Murine-Derived - pharmacokinetics | Rats | Receptors, IgG - immunology | Mice, Knockout | Signal Transduction - immunology | Animals | Signal Transduction - drug effects | Immunologic Capping - drug effects | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Mice | Antibodies, Monoclonal, Murine-Derived - pharmacology | CD40 Antigens - immunology | Index Medicus | Abridged Index Medicus
Journal Article
Molecular cancer therapeutics, ISSN 1535-7163, 01/2011, Volume 10, Issue 1, pp. 178 - 185
Life Sciences & Biomedicine | Oncology | Science & Technology | Antigens, CD20 - immunology | Dose-Response Relationship, Immunologic | Lymphoma, Follicular - drug therapy | Antibodies, Monoclonal - pharmacology | Humans | Rituximab | Gene Expression Profiling | Mice, SCID | Xenograft Model Antitumor Assays | Antibodies, Monoclonal, Humanized | Cyclophosphamide - blood | Antibodies, Monoclonal, Murine-Derived - blood | Animals | Lymphoma, Follicular - blood | Lymphoma, Follicular - genetics | Lymphoma, Follicular - immunology | Cyclophosphamide - pharmacology | Cell Line, Tumor | Female | Mice | Antibodies, Monoclonal, Murine-Derived - pharmacology | Antibodies, Monoclonal - immunology | Index Medicus | Antibodies, Monoclonal, Murine-Derived | Antigens, CD20 | Antibodies, Monoclonal | Life Sciences | Cyclophosphamide | Lymphoma, Follicular | Cancer
Journal Article
The New England journal of medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 5, pp. 417 - 427
WEGENERS-GRANULOMATOSIS | MAINTENANCE | ANTIBODY-ASSOCIATED VASCULITIS | RENAL VASCULITIS | CYCLOPHOSPHAMIDE | RITUXIMAB | ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES | RANDOMIZED-TRIAL | SYSTEMIC VASCULITIDES | CELL-ACTIVATION | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Recurrence | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Double-Blind Method | Drug Administration Schedule | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Immunologic Factors - administration & dosage | Kaplan-Meier Estimate | B-Lymphocytes | Rituximab | Cyclophosphamide - adverse effects | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Cyclophosphamide - therapeutic use | Immunosuppressive Agents - adverse effects | Immunologic Factors - adverse effects | Drug Therapy, Combination | Antibodies, Monoclonal, Murine-Derived - adverse effects | Azathioprine - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use | Immunosuppression | Vasculitis | Drug therapy | Patient outcomes | Disease | Medical treatment | Hypersensitivity | Patients | Immunosuppressive agents | Cyclophosphamide | Infectious diseases | Lymphocytes B | Antineutrophil cytoplasmic antibodies | Remission | Azathioprine | Index Medicus | Abridged Index Medicus
Journal Article
British journal of haematology, ISSN 0007-1048, 11/2011, Volume 155, Issue 4, pp. 498 - 508
common variable immunodeficiency | autoimmune haemolytic anaemia | Evans’ syndrome | immune thrombocytopenia | rituximab | Rituximab | Autoimmune haemolytic anaemia | Common variable immunodeficiency | Immune thrombocytopenia | Evans' syndrome | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Other diseases. Hematologic involvement in other diseases | Immunopathology | Biological and medical sciences | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Common Variable Immunodeficiency - drug therapy | Humans | Middle Aged | Thrombocytopenia - immunology | Anemia, Hemolytic, Autoimmune - drug therapy | Male | Common Variable Immunodeficiency - blood | Young Adult | Thrombocytopenia - drug therapy | Anemia, Hemolytic, Autoimmune - immunology | Adolescent | Adult | Female | Aged | Retrospective Studies | Antibodies, Monoclonal, Murine-Derived - adverse effects | Child | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Antimitotic agents | Medical colleges | Medical research | Immunoglobulins | Medicine, Experimental | Adults | Antineoplastic agents | Index Medicus | Thrombocytopenia | Antibodies, Monoclonal, Murine-Derived | Common Variable Immunodeficiency | Anemia, Hemolytic, Autoimmune | Life Sciences | Cancer
Journal Article